GEN PHARM
ActiveSummary
GEN PHARM has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €9,381 and a net result of -€5,339. Equity is shrinking by about 14% per year across the filed financial years. Its solvency ranks better than 85% of 1,052 sector peers (NACE 69, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Group and network
Connections & network
No directors read yet: 0 of 6 Gazette acts processed.